# Ferring Pharmaceuticals to build biotechnology centre in Saint-Prex

Swiss biopharmaceutical company Ferring Pharmaceuticals announced plans to build a biotechnology centre at its headquarters in Saint-Prex, Switzerland, with an investment of more than CHF30m ($32.06m) over three years. The centre will develop biologic drugs and manufacture APIs for Rekovelle.

- Type: New facility
- Announced: 2018-02-01
- Where: Saint-Prex, Switzerland
- Value: $32.1M (30.0M CHF)
- Starts operating: 2019
- Status: announced
- Products: biologic drugs, monoclonal antibodies, active pharmaceutical ingredients for Rekovelle
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ferring Pharmaceuticals](https://endata.com/companies/30065.md)

## Sources

- [pharmaceutical-technology.com](https://www.pharmaceutical-technology.com/projects/ferring-pharmaceuticals-biotechnology-saint-prex/), 2018-04-05: "The first lab of the biotech centre is expected to be operational in 2019."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.